Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Esophageal Neoplasms 1Atrial Fibrillation 1

Interventions

Specimen Handling 624pembrolizumab 603Magnetic Resonance Spectroscopy 550Carboplatin 444Cisplatin 394Cyclophosphamide 392Biopsy 368Paclitaxel 320Nivolumab 320Gemcitabine 313Radiotherapy 279Bevacizumab 242Dexamethasone 220fludarabine 210Docetaxel 197durvalumab 192Oxaliplatin 184venetoclax 182atezolizumab 182Fluorouracil 174Rituximab 172Pemetrexed 171Capecitabine 167Doxorubicin 164Radiation 162Radiosurgery 156Ipilimumab 143Etoposide 142Leucovorin 140Lenalidomide 136

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Amiodarone × 90 days × Clear all
NCT06067438 2026-05-22

Amiodarone for the Prevention of Atrial Fibrillation After Minimally Invasive Esophagectomy in Patients With Esophageal Cancer

OHSU Knight Cancer Institute

Phase 2 Recruiting
90 enrolled
Gastrointestinal

Atrial Fibrillation, Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡